Many pathology groups have a common misunderstanding when expanding into molecular testing: underestimating the operational burden of later ...
The aging brain frequently harbors multiple protein pathologies that contribute to Alzheimer's, Parkinson's and other ...
Alzheimer’s blood test breakthrough: 34 circular RNA biomarkers validated in nearly 2,400 patients outperform the pTau217 ...
Alcohol use has been associated with an increased risk of cognitive decline and dementia. But new research from Texas A&M ...
Post-COVID eye nerve damage leaves millions with corneal nerve loss and pupillary dysfunction that standard exams cannot ...
Alcohol use has been associated with an increased risk of cognitive decline and dementia. But new research from the Texas A&M ...
The aging brain frequently harbors multiple protein pathologies that contribute to Alzheimer's, Parkinson's and other ...
Women with Parkinson disease may face a significantly greater burden of Alzheimer disease-related amyloid plaque pathology compared with men.
AI can appear highly capable, yet remain surprisingly fragile to small changes in input. New research suggests AI fragility ...
A blood test does not lie, exactly. It reports a number. The question raised by a new mini-review in Brain Medicine, which ...
Older trial participants aren’t rejecting digital technology — they’re rejecting poorly designed, inaccessible experiences ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results